Tidal Investments’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Tidal Investments’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-55,400	Closed	-$350K	–	1408
2022 Q4	$350K	Sell	55,400 -7,078	-11%	-$39.2K	0.01%	774
2022 Q3	$320K	Buy	62,478 +1,388	+2%	+$8.72K	0.01%	722
2022 Q2	$382K	Buy	+61,090	New	+$206K	0.01%	692

Tidal Investments's FSTX Position: Q1 2023 in Review

Tidal Investments sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 55,400 shares — an estimated $350K sold.

Tidal Investments first reported a position in FSTX in Q2 2022 and held it in 3 quarters. The position peaked at $382K in Q2 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Tidal Investments reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Tidal Investments sold 55,400 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $350K.
Tidal Investments first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Tidal Investments's F-star Therapeutics, Inc. Common Stock position peaked at $382K in Q2 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Tidal Investments's 13F filing for Q1 2023, filed 15 May 2023.